US Patent Issued to Helix on Oct. 28 for "Dynamic risk management for breast cancer with multi-factor genetic testing" (California Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,456,552, issued on Oct. 28, was assigned to Helix Inc. (San Mateo, Calif.).

"Dynamic risk management for breast cancer with multi-factor genetic testing" was invented by Alexandre Bolze (San Francisco) and Joseph J. Grzymski (San Mateo, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Various embodiments disclosed relate to a method of preventive care for breast cancer. A method may include analyzing sequenced genetic data originating from the patient to determine whether the patient has a qualifying variant in any of genes BRCA1, BRCA2, PALB2, ATM, and CHEK2, wherein the qualifying variant can include one or more pathogenic variants, variants of u...